查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
非侵入性美容治療市場：按程序、性別、年齡層和最終用戶：2023-2032 年全球機會分析和行業預測
市場調查報告書
商品編碼
1414859

非侵入性美容治療市場：按程序、性別、年齡層和最終用戶：2023-2032 年全球機會分析和行業預測

Non-invasive Aesthetic Treatment Market By Procedure, By Gender, By Age Group, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 320 Pages | 商品交期: 2-3個工作天內

價格

2022年，非侵入性美容市場估值為155億美元，預計2023年至2032年複合年成長率為9.2%，到2032年達到375億美元。

無創美容市場-IMG1

非侵入性美容治療包括各種美容手術和治療方法，無需手術干預即可增強個人外觀並解決各種問題。這些治療旨在改善皮膚品質、減少老化徵兆並增強特定功能，與侵入性手術選擇相比，通常會減少不適感，恢復時間短，併發症風險低。常見的非侵入性治療包括肉毒桿菌注射、真皮填充劑、雷射治療、化學換膚和微晶換膚。這些治療方法通常針對以下問題：

(1) 皺紋、細紋、痤瘡疤痕、皮膚紋理不規則、體積減少。非侵入性美容產業的特點是技術不斷進步，社會壓力和對更年輕、更有吸引力的外觀的追求推動了需求的不斷成長。

老年人和年輕人對非侵入性美容治療方法的認知不斷提高，並且擴大採用這種治療方法來改善外觀，正在推動非侵入性美容治療市場的成長。例如，根據國際美容整形外科學會 (IASPS) 的數據，近年來，對 18 歲以下個體進行非手術減脂手術的數量穩步增加。 2020 年，ASPS 報告稱，大約有 24,488 例針對 18 歲以下人群進行的非手術減脂手術，佔所有非手術減脂手術的 3.4%。

目錄

第1章簡介

第 2 章執行摘要

第3章市場概況

  • 市場定義和範圍
  • 主要發現
    • 影響因素
    • 主要投資機會
  • 波特五力分析
  • 市場動態
    • 促進因素
      • 提高外觀意識
      • 更多地採用非侵入性整容手術
      • 非侵入性美容治療的技術進步
    • 抑制因素
      • 無創美容療程費用高
      • 結果不一致
    • 機會
      • 新興市場的成長機會

第4章 非侵入性美容醫學市場：依程序

  • 概述
  • 注射
  • 換膚
  • 其他

第5章無創美容市場：性別

  • 概述
  • 女士
  • 男性

第6章 無創美容醫學市場：依年齡段

  • 概述
  • 13歲至39歲
  • 40歲至54歲
  • 55歲至69歲
  • 70歲以上

第7章 非侵入性美容醫學市場：依最終使用者分類

  • 概述
  • 專科和皮膚科診所
  • 醫院
  • 其他

第8章無創美容醫學市場：按地區

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 其他
  • 拉丁美洲/中東/非洲
    • 巴西
    • 沙烏地阿拉伯
    • 南非
    • 其他

第9章 競爭形勢

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 2022年主要企業定位

第10章 公司簡介

  • Cynosure Inc
  • AbbVie Inc.
  • Sisram Medical Ltd.
  • Candela Corporation.
  • Lumenis Ltd.
  • Bausch Health Companies Inc.
  • MerzPharma
  • Fotona
  • HTM Eletronica
  • Cutera
Product Code: A210374

According to a new report published by Allied Market Research, titled, "Non-invasive Aesthetic Treatment Market," The non-invasive aesthetic treatment market was valued at $15.5 billion in 2022, and is estimated to reach $37.5 billion by 2032, growing at a CAGR of 9.2% from 2023 to 2032.

Non-invasive Aesthetic Treatment Market - IMG1

Non-invasive aesthetic treatment encompasses a wide range of cosmetic procedures and therapies that enhance an individual's physical appearance and address various concerns without the need for surgical intervention. These treatments are designed to improve skin quality, reduce signs of aging, and enhance specific features, often with minimal discomfort, minimal to no downtime, and a lower risk of complications compared to invasive surgical options. Common non-invasive treatments include Botox injections, dermal fillers, laser therapy, chemical peels, and microdermabrasion, among others. These procedures typically target issues such as

1) wrinkles, fine lines, acne scars, skin texture irregularities, and volume loss. The non-invasive aesthetic treatment industry is characterized by ongoing advancements in technology and a growing demand driven by societal pressures and the pursuit of a more youthful and appealing appearance.

The rise in awareness about non-invasive aesthetic treatment procedures, as well as the increase in adoption of this procedure among the elderly and young population for enhancing their appearance, is driving the growth of the non-invasive aesthetic treatment market. For instance, according to the International Society of Aesthetic Plastic Surgeons (IASPS), the number of non-surgical fat reduction procedures performed on individuals under the age of 18 has been steadily increasing in recent years. In 2020, the ASPS reported that there were approximately 24,488 non-surgical fat reduction procedures performed on individuals under the age of 18, which represents a 3.4% of the total non-surgical fat reduction procedures.

In addition, technological advancements play a pivotal role in driving the growth of the non-invasive aesthetics market. These innovations have revolutionized the industry by making procedures safer, more effective, and appealing to a wider range of patients. One significant impact of technological advancements is the development of non-invasive alternatives to surgical procedures. For instance, the introduction of advanced laser technology has enabled a variety of skin resurfacing and resurfacing procedures, including laser hair removal, tattoo removal, and skin tightening. These treatments often have reduced downtime, lower risk, and offer more predictable outcomes than their surgical counterparts. In addition, these advances have allowed for more comfortable and painless procedures, further encouraging patients to consider non-invasive aesthetic treatments.

However, the non-invasive aesthetics market faces growth restraints, primarily due to high costs and inconsistent results. The expense of these treatments be prohibitive for many individuals, limiting their accessibility. Moreover, inconsistent outcomes, varying from person to person, lead to patient dissatisfaction. The combination of cost concerns and uncertain results deter potential clients and affect market expansion, making affordability and effectiveness crucial considerations for both providers and patients.

The non-invasive aesthetic treatment market is segmented on the basis of procedure, gender, age group, and end user and region. On the basis of procedure, the market is classified into injectables, skin resurfacing, and others. The injectables segment is further divided into neurotoxins, HA filler and non-HA fillers. The skin resurfacing segment is further divided into chemical peel, laser skin resurfacing, and microdermabrasion. The others segment is further bifurcated into laser hair removal, non-surgical fat reduction, sclerotherapy and others. On the basis gender, the market is categorized into female and male. On the basis age group, the market is segregated into 13 to 39, 40 to 54, 55 to 69, age 70 and over. On the basis of end user, market is fragmented into specialty & dermatology clinics, hospital, and others. Region-wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

The major key players that operate in the global non-invasive aesthetic treatment market are Cynosure Inc Sisram Medical Ltd, Abbvie Inc, Lumenis Ltd., Candela Corporation, Fotona, HTM Eletronica MerzPharma., Cutera and Bausch Health Companies Inc.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the non-invasive aesthetic treatment market analysis from 2022 to 2032 to identify the prevailing non-invasive aesthetic treatment market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the non-invasive aesthetic treatment market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global non-invasive aesthetic treatment market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles
  • Historic market data

Key Market Segments

By Procedure

  • Injectables
    • Type
    • Neurotoxins
    • Hyaluronic Acid Fillers
    • Non Hyaluronic Fillers
  • Skin Resurfacing
    • Type
    • Microdermabration
    • Laser skin resurfacing
    • Chemical peel
  • Others
    • Type
    • Laser Hair Removal
    • Nonsurgical Fat Reduction
    • Sclerotherapy
    • Others

By Gender

  • Female
  • Male

By Age Group

  • 13 to 39
  • 40 to 54
  • 55 to 69
  • Age 70 and Over

By End User

  • Specialty and Dermatology Clinics
  • Hospitals
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Cynosure Inc
    • Sisram Medical Ltd.
    • Candela Corporation.
    • Fotona
    • HTM Eletronica
    • Cutera
    • AbbVie Inc.
    • Lumenis Ltd.
    • MerzPharma
    • Bausch Health Companies Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. High bargaining power of suppliers
    • 3.3.2. Modertae threat of new entrants
    • 3.3.3. Moderate threat of substitutes
    • 3.3.4. Modertae intensity of rivalry
    • 3.3.5. Moderate bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Increase in consciousness regarding physical appearance
      • 3.4.1.2. Rise in adoption of non-invasive aesthetic procedures
      • 3.4.1.3. Technological advancements in non-invasive aesthetic treatment
    • 3.4.2. Restraints
      • 3.4.2.1. High cost of non-invasive aesthetic treatment
      • 3.4.2.2. Inconsistent results
    • 3.4.3. Opportunities
      • 3.4.3.1. Growth opportunities in emerging markets

CHAPTER 4: NON-INVASIVE AESTHETIC TREATMENT MARKET, BY PROCEDURE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Injectables
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
    • 4.2.4. Injectables Non-invasive Aesthetic Treatment Market by Type
  • 4.3. Skin Resurfacing
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
    • 4.3.4. Skin Resurfacing Non-invasive Aesthetic Treatment Market by Type
  • 4.4. Others
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
    • 4.4.4. Others Non-invasive Aesthetic Treatment Market by Type

CHAPTER 5: NON-INVASIVE AESTHETIC TREATMENT MARKET, BY GENDER

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Female
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Male
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country

CHAPTER 6: NON-INVASIVE AESTHETIC TREATMENT MARKET, BY AGE GROUP

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. 13 to 39
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. 40 to 54
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. 55 to 69
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country
  • 6.5. Age 70 and Over
    • 6.5.1. Key market trends, growth factors and opportunities
    • 6.5.2. Market size and forecast, by region
    • 6.5.3. Market share analysis by country

CHAPTER 7: NON-INVASIVE AESTHETIC TREATMENT MARKET, BY END USER

  • 7.1. Overview
    • 7.1.1. Market size and forecast
  • 7.2. Specialty and Dermatology Clinics
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by region
    • 7.2.3. Market share analysis by country
  • 7.3. Hospitals
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by region
    • 7.3.3. Market share analysis by country
  • 7.4. Others
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by region
    • 7.4.3. Market share analysis by country

CHAPTER 8: NON-INVASIVE AESTHETIC TREATMENT MARKET, BY REGION

  • 8.1. Overview
    • 8.1.1. Market size and forecast By Region
  • 8.2. North America
    • 8.2.1. Key market trends, growth factors and opportunities
    • 8.2.2. Market size and forecast, by Procedure
    • 8.2.3. Market size and forecast, by Gender
    • 8.2.4. Market size and forecast, by Age Group
    • 8.2.5. Market size and forecast, by End User
    • 8.2.6. Market size and forecast, by country
      • 8.2.6.1. U.S.
      • 8.2.6.1.1. Market size and forecast, by Procedure
      • 8.2.6.1.2. Market size and forecast, by Gender
      • 8.2.6.1.3. Market size and forecast, by Age Group
      • 8.2.6.1.4. Market size and forecast, by End User
      • 8.2.6.2. Canada
      • 8.2.6.2.1. Market size and forecast, by Procedure
      • 8.2.6.2.2. Market size and forecast, by Gender
      • 8.2.6.2.3. Market size and forecast, by Age Group
      • 8.2.6.2.4. Market size and forecast, by End User
      • 8.2.6.3. Mexico
      • 8.2.6.3.1. Market size and forecast, by Procedure
      • 8.2.6.3.2. Market size and forecast, by Gender
      • 8.2.6.3.3. Market size and forecast, by Age Group
      • 8.2.6.3.4. Market size and forecast, by End User
  • 8.3. Europe
    • 8.3.1. Key market trends, growth factors and opportunities
    • 8.3.2. Market size and forecast, by Procedure
    • 8.3.3. Market size and forecast, by Gender
    • 8.3.4. Market size and forecast, by Age Group
    • 8.3.5. Market size and forecast, by End User
    • 8.3.6. Market size and forecast, by country
      • 8.3.6.1. Germany
      • 8.3.6.1.1. Market size and forecast, by Procedure
      • 8.3.6.1.2. Market size and forecast, by Gender
      • 8.3.6.1.3. Market size and forecast, by Age Group
      • 8.3.6.1.4. Market size and forecast, by End User
      • 8.3.6.2. France
      • 8.3.6.2.1. Market size and forecast, by Procedure
      • 8.3.6.2.2. Market size and forecast, by Gender
      • 8.3.6.2.3. Market size and forecast, by Age Group
      • 8.3.6.2.4. Market size and forecast, by End User
      • 8.3.6.3. UK
      • 8.3.6.3.1. Market size and forecast, by Procedure
      • 8.3.6.3.2. Market size and forecast, by Gender
      • 8.3.6.3.3. Market size and forecast, by Age Group
      • 8.3.6.3.4. Market size and forecast, by End User
      • 8.3.6.4. Italy
      • 8.3.6.4.1. Market size and forecast, by Procedure
      • 8.3.6.4.2. Market size and forecast, by Gender
      • 8.3.6.4.3. Market size and forecast, by Age Group
      • 8.3.6.4.4. Market size and forecast, by End User
      • 8.3.6.5. Spain
      • 8.3.6.5.1. Market size and forecast, by Procedure
      • 8.3.6.5.2. Market size and forecast, by Gender
      • 8.3.6.5.3. Market size and forecast, by Age Group
      • 8.3.6.5.4. Market size and forecast, by End User
      • 8.3.6.6. Rest of Europe
      • 8.3.6.6.1. Market size and forecast, by Procedure
      • 8.3.6.6.2. Market size and forecast, by Gender
      • 8.3.6.6.3. Market size and forecast, by Age Group
      • 8.3.6.6.4. Market size and forecast, by End User
  • 8.4. Asia-Pacific
    • 8.4.1. Key market trends, growth factors and opportunities
    • 8.4.2. Market size and forecast, by Procedure
    • 8.4.3. Market size and forecast, by Gender
    • 8.4.4. Market size and forecast, by Age Group
    • 8.4.5. Market size and forecast, by End User
    • 8.4.6. Market size and forecast, by country
      • 8.4.6.1. Japan
      • 8.4.6.1.1. Market size and forecast, by Procedure
      • 8.4.6.1.2. Market size and forecast, by Gender
      • 8.4.6.1.3. Market size and forecast, by Age Group
      • 8.4.6.1.4. Market size and forecast, by End User
      • 8.4.6.2. China
      • 8.4.6.2.1. Market size and forecast, by Procedure
      • 8.4.6.2.2. Market size and forecast, by Gender
      • 8.4.6.2.3. Market size and forecast, by Age Group
      • 8.4.6.2.4. Market size and forecast, by End User
      • 8.4.6.3. India
      • 8.4.6.3.1. Market size and forecast, by Procedure
      • 8.4.6.3.2. Market size and forecast, by Gender
      • 8.4.6.3.3. Market size and forecast, by Age Group
      • 8.4.6.3.4. Market size and forecast, by End User
      • 8.4.6.4. Australia
      • 8.4.6.4.1. Market size and forecast, by Procedure
      • 8.4.6.4.2. Market size and forecast, by Gender
      • 8.4.6.4.3. Market size and forecast, by Age Group
      • 8.4.6.4.4. Market size and forecast, by End User
      • 8.4.6.5. South Korea
      • 8.4.6.5.1. Market size and forecast, by Procedure
      • 8.4.6.5.2. Market size and forecast, by Gender
      • 8.4.6.5.3. Market size and forecast, by Age Group
      • 8.4.6.5.4. Market size and forecast, by End User
      • 8.4.6.6. Rest of Asia-Pacific
      • 8.4.6.6.1. Market size and forecast, by Procedure
      • 8.4.6.6.2. Market size and forecast, by Gender
      • 8.4.6.6.3. Market size and forecast, by Age Group
      • 8.4.6.6.4. Market size and forecast, by End User
  • 8.5. LAMEA
    • 8.5.1. Key market trends, growth factors and opportunities
    • 8.5.2. Market size and forecast, by Procedure
    • 8.5.3. Market size and forecast, by Gender
    • 8.5.4. Market size and forecast, by Age Group
    • 8.5.5. Market size and forecast, by End User
    • 8.5.6. Market size and forecast, by country
      • 8.5.6.1. Brazil
      • 8.5.6.1.1. Market size and forecast, by Procedure
      • 8.5.6.1.2. Market size and forecast, by Gender
      • 8.5.6.1.3. Market size and forecast, by Age Group
      • 8.5.6.1.4. Market size and forecast, by End User
      • 8.5.6.2. Saudi Arabia
      • 8.5.6.2.1. Market size and forecast, by Procedure
      • 8.5.6.2.2. Market size and forecast, by Gender
      • 8.5.6.2.3. Market size and forecast, by Age Group
      • 8.5.6.2.4. Market size and forecast, by End User
      • 8.5.6.3. South Africa
      • 8.5.6.3.1. Market size and forecast, by Procedure
      • 8.5.6.3.2. Market size and forecast, by Gender
      • 8.5.6.3.3. Market size and forecast, by Age Group
      • 8.5.6.3.4. Market size and forecast, by End User
      • 8.5.6.4. Rest of LAMEA
      • 8.5.6.4.1. Market size and forecast, by Procedure
      • 8.5.6.4.2. Market size and forecast, by Gender
      • 8.5.6.4.3. Market size and forecast, by Age Group
      • 8.5.6.4.4. Market size and forecast, by End User

CHAPTER 9: COMPETITIVE LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top winning strategies
  • 9.3. Product mapping of top 10 player
  • 9.4. Competitive dashboard
  • 9.5. Competitive heatmap
  • 9.6. Top player positioning, 2022

CHAPTER 10: COMPANY PROFILES

  • 10.1. Cynosure Inc
    • 10.1.1. Company overview
    • 10.1.2. Key executives
    • 10.1.3. Company snapshot
    • 10.1.4. Operating business segments
    • 10.1.5. Product portfolio
  • 10.2. AbbVie Inc.
    • 10.2.1. Company overview
    • 10.2.2. Key executives
    • 10.2.3. Company snapshot
    • 10.2.4. Operating business segments
    • 10.2.5. Product portfolio
    • 10.2.6. Business performance
    • 10.2.7. Key strategic moves and developments
  • 10.3. Sisram Medical Ltd.
    • 10.3.1. Company overview
    • 10.3.2. Key executives
    • 10.3.3. Company snapshot
    • 10.3.4. Operating business segments
    • 10.3.5. Product portfolio
    • 10.3.6. Business performance
  • 10.4. Candela Corporation.
    • 10.4.1. Company overview
    • 10.4.2. Key executives
    • 10.4.3. Company snapshot
    • 10.4.4. Operating business segments
    • 10.4.5. Product portfolio
    • 10.4.6. Key strategic moves and developments
  • 10.5. Lumenis Ltd.
    • 10.5.1. Company overview
    • 10.5.2. Key executives
    • 10.5.3. Company snapshot
    • 10.5.4. Operating business segments
    • 10.5.5. Product portfolio
    • 10.5.6. Key strategic moves and developments
  • 10.6. Bausch Health Companies Inc.
    • 10.6.1. Company overview
    • 10.6.2. Key executives
    • 10.6.3. Company snapshot
    • 10.6.4. Operating business segments
    • 10.6.5. Product portfolio
    • 10.6.6. Business performance
  • 10.7. MerzPharma
    • 10.7.1. Company overview
    • 10.7.2. Key executives
    • 10.7.3. Company snapshot
    • 10.7.4. Operating business segments
    • 10.7.5. Product portfolio
  • 10.8. Fotona
    • 10.8.1. Company overview
    • 10.8.2. Key executives
    • 10.8.3. Company snapshot
    • 10.8.4. Operating business segments
    • 10.8.5. Product portfolio
  • 10.9. HTM Eletronica
    • 10.9.1. Company overview
    • 10.9.2. Key executives
    • 10.9.3. Company snapshot
    • 10.9.4. Operating business segments
    • 10.9.5. Product portfolio
  • 10.10. Cutera
    • 10.10.1. Company overview
    • 10.10.2. Key executives
    • 10.10.3. Company snapshot
    • 10.10.4. Operating business segments
    • 10.10.5. Product portfolio
    • 10.10.6. Business performance
    • 10.10.7. Key strategic moves and developments

LIST OF TABLES

  • TABLE 01. GLOBAL NON-INVASIVE AESTHETIC TREATMENT MARKET, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 02. NON-INVASIVE AESTHETIC TREATMENT MARKET FOR INJECTABLES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. GLOBAL INJECTABLES NON-INVASIVE AESTHETIC TREATMENT MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 04. NON-INVASIVE AESTHETIC TREATMENT MARKET FOR SKIN RESURFACING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 05. GLOBAL SKIN RESURFACING NON-INVASIVE AESTHETIC TREATMENT MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 06. NON-INVASIVE AESTHETIC TREATMENT MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. GLOBAL OTHERS NON-INVASIVE AESTHETIC TREATMENT MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 08. GLOBAL NON-INVASIVE AESTHETIC TREATMENT MARKET, BY GENDER, 2022-2032 ($MILLION)
  • TABLE 09. NON-INVASIVE AESTHETIC TREATMENT MARKET FOR FEMALE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. NON-INVASIVE AESTHETIC TREATMENT MARKET FOR MALE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL NON-INVASIVE AESTHETIC TREATMENT MARKET, BY AGE GROUP, 2022-2032 ($MILLION)
  • TABLE 12. NON-INVASIVE AESTHETIC TREATMENT MARKET FOR 13 TO 39, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. NON-INVASIVE AESTHETIC TREATMENT MARKET FOR 40 TO 54, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. NON-INVASIVE AESTHETIC TREATMENT MARKET FOR 55 TO 69, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. NON-INVASIVE AESTHETIC TREATMENT MARKET FOR AGE 70 AND OVER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. GLOBAL NON-INVASIVE AESTHETIC TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 17. NON-INVASIVE AESTHETIC TREATMENT MARKET FOR SPECIALTY AND DERMATOLOGY CLINICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. NON-INVASIVE AESTHETIC TREATMENT MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. NON-INVASIVE AESTHETIC TREATMENT MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. NON-INVASIVE AESTHETIC TREATMENT MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 21. NORTH AMERICA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 22. NORTH AMERICA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY GENDER, 2022-2032 ($MILLION)
  • TABLE 23. NORTH AMERICA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY AGE GROUP, 2022-2032 ($MILLION)
  • TABLE 24. NORTH AMERICA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 25. NORTH AMERICA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 26. U.S. NON-INVASIVE AESTHETIC TREATMENT MARKET, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 27. U.S. NON-INVASIVE AESTHETIC TREATMENT MARKET, BY GENDER, 2022-2032 ($MILLION)
  • TABLE 28. U.S. NON-INVASIVE AESTHETIC TREATMENT MARKET, BY AGE GROUP, 2022-2032 ($MILLION)
  • TABLE 29. U.S. NON-INVASIVE AESTHETIC TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 30. CANADA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 31. CANADA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY GENDER, 2022-2032 ($MILLION)
  • TABLE 32. CANADA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY AGE GROUP, 2022-2032 ($MILLION)
  • TABLE 33. CANADA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 34. MEXICO NON-INVASIVE AESTHETIC TREATMENT MARKET, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 35. MEXICO NON-INVASIVE AESTHETIC TREATMENT MARKET, BY GENDER, 2022-2032 ($MILLION)
  • TABLE 36. MEXICO NON-INVASIVE AESTHETIC TREATMENT MARKET, BY AGE GROUP, 2022-2032 ($MILLION)
  • TABLE 37. MEXICO NON-INVASIVE AESTHETIC TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 38. EUROPE NON-INVASIVE AESTHETIC TREATMENT MARKET, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 39. EUROPE NON-INVASIVE AESTHETIC TREATMENT MARKET, BY GENDER, 2022-2032 ($MILLION)
  • TABLE 40. EUROPE NON-INVASIVE AESTHETIC TREATMENT MARKET, BY AGE GROUP, 2022-2032 ($MILLION)
  • TABLE 41. EUROPE NON-INVASIVE AESTHETIC TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 42. EUROPE NON-INVASIVE AESTHETIC TREATMENT MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 43. GERMANY NON-INVASIVE AESTHETIC TREATMENT MARKET, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 44. GERMANY NON-INVASIVE AESTHETIC TREATMENT MARKET, BY GENDER, 2022-2032 ($MILLION)
  • TABLE 45. GERMANY NON-INVASIVE AESTHETIC TREATMENT MARKET, BY AGE GROUP, 2022-2032 ($MILLION)
  • TABLE 46. GERMANY NON-INVASIVE AESTHETIC TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 47. FRANCE NON-INVASIVE AESTHETIC TREATMENT MARKET, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 48. FRANCE NON-INVASIVE AESTHETIC TREATMENT MARKET, BY GENDER, 2022-2032 ($MILLION)
  • TABLE 49. FRANCE NON-INVASIVE AESTHETIC TREATMENT MARKET, BY AGE GROUP, 2022-2032 ($MILLION)
  • TABLE 50. FRANCE NON-INVASIVE AESTHETIC TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 51. UK NON-INVASIVE AESTHETIC TREATMENT MARKET, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 52. UK NON-INVASIVE AESTHETIC TREATMENT MARKET, BY GENDER, 2022-2032 ($MILLION)
  • TABLE 53. UK NON-INVASIVE AESTHETIC TREATMENT MARKET, BY AGE GROUP, 2022-2032 ($MILLION)
  • TABLE 54. UK NON-INVASIVE AESTHETIC TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 55. ITALY NON-INVASIVE AESTHETIC TREATMENT MARKET, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 56. ITALY NON-INVASIVE AESTHETIC TREATMENT MARKET, BY GENDER, 2022-2032 ($MILLION)
  • TABLE 57. ITALY NON-INVASIVE AESTHETIC TREATMENT MARKET, BY AGE GROUP, 2022-2032 ($MILLION)
  • TABLE 58. ITALY NON-INVASIVE AESTHETIC TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 59. SPAIN NON-INVASIVE AESTHETIC TREATMENT MARKET, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 60. SPAIN NON-INVASIVE AESTHETIC TREATMENT MARKET, BY GENDER, 2022-2032 ($MILLION)
  • TABLE 61. SPAIN NON-INVASIVE AESTHETIC TREATMENT MARKET, BY AGE GROUP, 2022-2032 ($MILLION)
  • TABLE 62. SPAIN NON-INVASIVE AESTHETIC TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 63. REST OF EUROPE NON-INVASIVE AESTHETIC TREATMENT MARKET, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 64. REST OF EUROPE NON-INVASIVE AESTHETIC TREATMENT MARKET, BY GENDER, 2022-2032 ($MILLION)
  • TABLE 65. REST OF EUROPE NON-INVASIVE AESTHETIC TREATMENT MARKET, BY AGE GROUP, 2022-2032 ($MILLION)
  • TABLE 66. REST OF EUROPE NON-INVASIVE AESTHETIC TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 67. ASIA-PACIFIC NON-INVASIVE AESTHETIC TREATMENT MARKET, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 68. ASIA-PACIFIC NON-INVASIVE AESTHETIC TREATMENT MARKET, BY GENDER, 2022-2032 ($MILLION)
  • TABLE 69. ASIA-PACIFIC NON-INVASIVE AESTHETIC TREATMENT MARKET, BY AGE GROUP, 2022-2032 ($MILLION)
  • TABLE 70. ASIA-PACIFIC NON-INVASIVE AESTHETIC TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 71. ASIA-PACIFIC NON-INVASIVE AESTHETIC TREATMENT MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 72. JAPAN NON-INVASIVE AESTHETIC TREATMENT MARKET, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 73. JAPAN NON-INVASIVE AESTHETIC TREATMENT MARKET, BY GENDER, 2022-2032 ($MILLION)
  • TABLE 74. JAPAN NON-INVASIVE AESTHETIC TREATMENT MARKET, BY AGE GROUP, 2022-2032 ($MILLION)
  • TABLE 75. JAPAN NON-INVASIVE AESTHETIC TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 76. CHINA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 77. CHINA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY GENDER, 2022-2032 ($MILLION)
  • TABLE 78. CHINA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY AGE GROUP, 2022-2032 ($MILLION)
  • TABLE 79. CHINA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 80. INDIA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 81. INDIA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY GENDER, 2022-2032 ($MILLION)
  • TABLE 82. INDIA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY AGE GROUP, 2022-2032 ($MILLION)
  • TABLE 83. INDIA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 84. AUSTRALIA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 85. AUSTRALIA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY GENDER, 2022-2032 ($MILLION)
  • TABLE 86. AUSTRALIA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY AGE GROUP, 2022-2032 ($MILLION)
  • TABLE 87. AUSTRALIA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 88. SOUTH KOREA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 89. SOUTH KOREA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY GENDER, 2022-2032 ($MILLION)
  • TABLE 90. SOUTH KOREA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY AGE GROUP, 2022-2032 ($MILLION)
  • TABLE 91. SOUTH KOREA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 92. REST OF ASIA-PACIFIC NON-INVASIVE AESTHETIC TREATMENT MARKET, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 93. REST OF ASIA-PACIFIC NON-INVASIVE AESTHETIC TREATMENT MARKET, BY GENDER, 2022-2032 ($MILLION)
  • TABLE 94. REST OF ASIA-PACIFIC NON-INVASIVE AESTHETIC TREATMENT MARKET, BY AGE GROUP, 2022-2032 ($MILLION)
  • TABLE 95. REST OF ASIA-PACIFIC NON-INVASIVE AESTHETIC TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 96. LAMEA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 97. LAMEA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY GENDER, 2022-2032 ($MILLION)
  • TABLE 98. LAMEA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY AGE GROUP, 2022-2032 ($MILLION)
  • TABLE 99. LAMEA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 100. LAMEA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 101. BRAZIL NON-INVASIVE AESTHETIC TREATMENT MARKET, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 102. BRAZIL NON-INVASIVE AESTHETIC TREATMENT MARKET, BY GENDER, 2022-2032 ($MILLION)
  • TABLE 103. BRAZIL NON-INVASIVE AESTHETIC TREATMENT MARKET, BY AGE GROUP, 2022-2032 ($MILLION)
  • TABLE 104. BRAZIL NON-INVASIVE AESTHETIC TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 105. SAUDI ARABIA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 106. SAUDI ARABIA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY GENDER, 2022-2032 ($MILLION)
  • TABLE 107. SAUDI ARABIA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY AGE GROUP, 2022-2032 ($MILLION)
  • TABLE 108. SAUDI ARABIA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 109. SOUTH AFRICA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 110. SOUTH AFRICA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY GENDER, 2022-2032 ($MILLION)
  • TABLE 111. SOUTH AFRICA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY AGE GROUP, 2022-2032 ($MILLION)
  • TABLE 112. SOUTH AFRICA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 113. REST OF LAMEA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY PROCEDURE, 2022-2032 ($MILLION)
  • TABLE 114. REST OF LAMEA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY GENDER, 2022-2032 ($MILLION)
  • TABLE 115. REST OF LAMEA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY AGE GROUP, 2022-2032 ($MILLION)
  • TABLE 116. REST OF LAMEA NON-INVASIVE AESTHETIC TREATMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 117. CYNOSURE INC: KEY EXECUTIVES
  • TABLE 118. CYNOSURE INC: COMPANY SNAPSHOT
  • TABLE 119. CYNOSURE INC: PRODUCT SEGMENTS
  • TABLE 120. CYNOSURE INC: PRODUCT PORTFOLIO
  • TABLE 121. ABBVIE INC.: KEY EXECUTIVES
  • TABLE 122. ABBVIE INC.: COMPANY SNAPSHOT
  • TABLE 123. ABBVIE INC.: PRODUCT SEGMENTS
  • TABLE 124. ABBVIE INC.: PRODUCT PORTFOLIO
  • TABLE 125. ABBVIE INC.: KEY STRATERGIES
  • TABLE 126. SISRAM MEDICAL LTD.: KEY EXECUTIVES
  • TABLE 127. SISRAM MEDICAL LTD.: COMPANY SNAPSHOT
  • TABLE 128. SISRAM MEDICAL LTD.: PRODUCT SEGMENTS
  • TABLE 129. SISRAM MEDICAL LTD.: PRODUCT PORTFOLIO
  • TABLE 130. CANDELA CORPORATION.: KEY EXECUTIVES
  • TABLE 131. CANDELA CORPORATION.: COMPANY SNAPSHOT
  • TABLE 132. CANDELA CORPORATION.: PRODUCT SEGMENTS
  • TABLE 133. CANDELA CORPORATION.: PRODUCT PORTFOLIO
  • TABLE 134. CANDELA CORPORATION.: KEY STRATERGIES
  • TABLE 135. LUMENIS LTD.: KEY EXECUTIVES
  • TABLE 136. LUMENIS LTD.: COMPANY SNAPSHOT
  • TABLE 137. LUMENIS LTD.: PRODUCT SEGMENTS
  • TABLE 138. LUMENIS LTD.: PRODUCT PORTFOLIO
  • TABLE 139. LUMENIS LTD.: KEY STRATERGIES
  • TABLE 140. BAUSCH HEALTH COMPANIES INC.: KEY EXECUTIVES
  • TABLE 141. BAUSCH HEALTH COMPANIES INC.: COMPANY SNAPSHOT
  • TABLE 142. BAUSCH HEALTH COMPANIES INC.: PRODUCT SEGMENTS
  • TABLE 143. BAUSCH HEALTH COMPANIES INC.: PRODUCT PORTFOLIO
  • TABLE 144. MERZPHARMA: KEY EXECUTIVES
  • TABLE 145. MERZPHARMA: COMPANY SNAPSHOT
  • TABLE 146. MERZPHARMA: PRODUCT SEGMENTS
  • TABLE 147. MERZPHARMA: PRODUCT PORTFOLIO
  • TABLE 148. FOTONA: KEY EXECUTIVES
  • TABLE 149. FOTONA: COMPANY SNAPSHOT
  • TABLE 150. FOTONA: PRODUCT SEGMENTS
  • TABLE 151. FOTONA: PRODUCT PORTFOLIO
  • TABLE 152. HTM ELETRONICA: KEY EXECUTIVES
  • TABLE 153. HTM ELETRONICA: COMPANY SNAPSHOT
  • TABLE 154. HTM ELETRONICA: PRODUCT SEGMENTS
  • TABLE 155. HTM ELETRONICA: PRODUCT PORTFOLIO
  • TABLE 156. CUTERA: KEY EXECUTIVES
  • TABLE 157. CUTERA: COMPANY SNAPSHOT
  • TABLE 158. CUTERA: PRODUCT SEGMENTS
  • TABLE 159. CUTERA: PRODUCT PORTFOLIO
  • TABLE 160. CUTERA: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 01. NON-INVASIVE AESTHETIC TREATMENT MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF NON-INVASIVE AESTHETIC TREATMENT MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN NON-INVASIVE AESTHETIC TREATMENT MARKET (2022 TO 2032)
  • FIGURE 04. TOP INVESTMENT POCKETS IN NON-INVASIVE AESTHETIC TREATMENT MARKET (2023-2032)
  • FIGURE 05. HIGH BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. MODERTAE THREAT OF NEW ENTRANTS
  • FIGURE 07. MODERATE THREAT OF SUBSTITUTES
  • FIGURE 08. MODERTAE INTENSITY OF RIVALRY
  • FIGURE 09. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 10. GLOBAL NON-INVASIVE AESTHETIC TREATMENT MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. NON-INVASIVE AESTHETIC TREATMENT MARKET, BY PROCEDURE, 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF NON-INVASIVE AESTHETIC TREATMENT MARKET FOR INJECTABLES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF NON-INVASIVE AESTHETIC TREATMENT MARKET FOR SKIN RESURFACING, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF NON-INVASIVE AESTHETIC TREATMENT MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 15. NON-INVASIVE AESTHETIC TREATMENT MARKET, BY GENDER, 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF NON-INVASIVE AESTHETIC TREATMENT MARKET FOR FEMALE, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF NON-INVASIVE AESTHETIC TREATMENT MARKET FOR MALE, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. NON-INVASIVE AESTHETIC TREATMENT MARKET, BY AGE GROUP, 2022 AND 2032(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF NON-INVASIVE AESTHETIC TREATMENT MARKET FOR 13 TO 39, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF NON-INVASIVE AESTHETIC TREATMENT MARKET FOR 40 TO 54, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF NON-INVASIVE AESTHETIC TREATMENT MARKET FOR 55 TO 69, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF NON-INVASIVE AESTHETIC TREATMENT MARKET FOR AGE 70 AND OVER, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 23. NON-INVASIVE AESTHETIC TREATMENT MARKET, BY END USER, 2022 AND 2032(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF NON-INVASIVE AESTHETIC TREATMENT MARKET FOR SPECIALTY AND DERMATOLOGY CLINICS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 25. COMPARATIVE SHARE ANALYSIS OF NON-INVASIVE AESTHETIC TREATMENT MARKET FOR HOSPITALS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 26. COMPARATIVE SHARE ANALYSIS OF NON-INVASIVE AESTHETIC TREATMENT MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 27. NON-INVASIVE AESTHETIC TREATMENT MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 28. U.S. NON-INVASIVE AESTHETIC TREATMENT MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. CANADA NON-INVASIVE AESTHETIC TREATMENT MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. MEXICO NON-INVASIVE AESTHETIC TREATMENT MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. GERMANY NON-INVASIVE AESTHETIC TREATMENT MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. FRANCE NON-INVASIVE AESTHETIC TREATMENT MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. UK NON-INVASIVE AESTHETIC TREATMENT MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. ITALY NON-INVASIVE AESTHETIC TREATMENT MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. SPAIN NON-INVASIVE AESTHETIC TREATMENT MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. REST OF EUROPE NON-INVASIVE AESTHETIC TREATMENT MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. JAPAN NON-INVASIVE AESTHETIC TREATMENT MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. CHINA NON-INVASIVE AESTHETIC TREATMENT MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. INDIA NON-INVASIVE AESTHETIC TREATMENT MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. AUSTRALIA NON-INVASIVE AESTHETIC TREATMENT MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. SOUTH KOREA NON-INVASIVE AESTHETIC TREATMENT MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. REST OF ASIA-PACIFIC NON-INVASIVE AESTHETIC TREATMENT MARKET, 2022-2032 ($MILLION)
  • FIGURE 43. BRAZIL NON-INVASIVE AESTHETIC TREATMENT MARKET, 2022-2032 ($MILLION)
  • FIGURE 44. SAUDI ARABIA NON-INVASIVE AESTHETIC TREATMENT MARKET, 2022-2032 ($MILLION)
  • FIGURE 45. SOUTH AFRICA NON-INVASIVE AESTHETIC TREATMENT MARKET, 2022-2032 ($MILLION)
  • FIGURE 46. REST OF LAMEA NON-INVASIVE AESTHETIC TREATMENT MARKET, 2022-2032 ($MILLION)
  • FIGURE 47. TOP WINNING STRATEGIES, BY YEAR (2020-2023)
  • FIGURE 48. TOP WINNING STRATEGIES, BY DEVELOPMENT (2020-2023)
  • FIGURE 49. TOP WINNING STRATEGIES, BY COMPANY (2020-2023)
  • FIGURE 50. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 51. COMPETITIVE DASHBOARD
  • FIGURE 52. COMPETITIVE HEATMAP: NON-INVASIVE AESTHETIC TREATMENT MARKET
  • FIGURE 53. TOP PLAYER POSITIONING, 2022
  • FIGURE 54. ABBVIE INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 55. ABBVIE INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 56. ABBVIE INC.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 57. SISRAM MEDICAL LTD.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 58. SISRAM MEDICAL LTD.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 59. SISRAM MEDICAL LTD.: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 60. BAUSCH HEALTH COMPANIES INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 61. BAUSCH HEALTH COMPANIES INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 62. BAUSCH HEALTH COMPANIES INC.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 63. CUTERA: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 64. CUTERA: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 65. CUTERA: REVENUE SHARE BY SEGMENT, 2022 (%)